Sept. 29, 2013
Researchers in Sweden said Friday they had developed a new medicine to protect bees from diseases that kill entire populations of the insect in the US and Europe.
A team of microbiologists at Lund University have patented the treatment, known as SymBeeotic — made from lactic acid bacteria from the stomachs of healthy bees — which they described as a major “boost” to bees’ immune system and are hopeful that it could slow down the rate at which bees are dying.
“The bacteria in this product is active against both American and European foulbrood disease,” Dr Alejandra Vasquez, who co-developed the product, told AFP. Foulbrood is the fatal bacterial disease which threatens bees.
This article was posted: Sunday, September 29, 2013 at 11:27 am
<!– this is where we need to show the related articles